Three issues: Law/Fact Distinction in Obviousness; Envisaging the Invention; and Newman in Dissent

U.S. Patent Nos. 8,257,723 and 7,744,913. Palette Life Sciences initiated IPR proceedings and the PTAB eventually found the challenged claims …